bshah
@bshah
Followers
201
Following
455
Statuses
449
Joined July 2008
@DavidSteensma @NEJM Perhaps, but need to counterbalance with chemotherapy associated risks. Maybe better to ask - can we avoid?
0
0
1
RT @DrDamluji: Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation: @NEJM š„øSummary ššš
0
152
0
RT @MoffittNews: Drs. Minnie and Mickey Mouse heard about the Clinical Breakthroughs and Challenges in Hematologic Malignancies conferenceā¦
0
3
0
RT @MoffittNews: At #Heme25, Moffitt experts present during the Multiple Myeloma session, highlighting challenges and emerging ways to imprā¦
0
2
0
RT @MoffittNews: Live from #Heme2025: Rami Komrokji, MD (@Ramikomrokji) leads an interactive case discussion on managing anemia in lower-riā¦
0
1
0
RT @MoffittNews: We are excited to kick off the 20th Annual Clinical Breakthroughs and Challenges in Hematologic Malignancies conference! Tā¦
0
3
0
RT @MoffittNews: During the #Heme2025 conference, Moffitt experts explore whether itās time to bring T cell therapy to the frontline for loā¦
0
1
0
RT @VJHemOnc: Want to hear the updated results from a Phase I/II trial of golcadomide Ā± rituximab in R/R #FollicularLymphoma? Watch our inā¦
0
1
0
@drjgauthier @mshadman @BloodAdvances @ekimblepl @xanhira Great work! Did you see immune response against the humanized car construct at similar rates?
1
0
1
RT @michaelwangmd: FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma | FDA https://tā¦
0
20
0
0
0
0
2024: The Year in Experimental Medicine | Journal of Experimental Medicine | Rockefeller University Press
0
0
1
Scienceās 2024 Breakthrough of the Year: Opening the door to a new era of HIV prevention | Science | AAAS
0
0
3
RT @MoffittHemOnc: š Weāre thrilled to announce our fantastic match results! š· Congratulations to our 2025-2028 incoming Moffitt/USF Hem/Oā¦
0
8
0
